No Data
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Least Shorted S&P 500 Stocks in September
Lilly Confirms Date and Conference Call for Third-quarter 2024 Financial Results Announcement
Express News | Sunbird Bio: Raises $14 Mln, Backed by Eli Lilly and Strategic Investment Arm of Singapore Economic Development Board, Edbi
DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025